NCS Multistage (NCSM) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Dec, 2025Executive summary
Q1 2025 revenue reached $50 million, up 14% year-over-year and 11% sequentially, marking the highest quarterly revenue since Q1 2020, driven by strong Canadian and international sales.
Net income rose to $4.1 million ($1.51 per diluted share), nearly doubling from $2.1 million ($0.82 per share) a year ago.
Adjusted EBITDA improved to $8.2 million, up $2.1 million year-over-year, with margin rising to 16% from 14%.
Gross margin improved to 44% from 40% a year ago, reflecting higher-margin international work and Canadian sales.
The company operates in one reportable segment, focusing on engineered products and services for oil and gas well construction and completions.
Financial highlights
Product sales were $35.1 million (up 10.4%) and services $14.9 million (up 23.5%) year-over-year.
Adjusted gross profit was $21.9 million, with adjusted gross margin rising to 44% from 40% a year ago.
SG&A expenses increased, mainly due to higher incentive bonuses and share-based compensation.
Cash and cash equivalents were $23 million as of March 31, 2025; total liquidity was approximately $50 million.
Free cash flow after distributions projected at $7–$11 million for 2025.
Outlook and guidance
Q2 2025 revenue expected between $26–$29 million, with Canadian revenue $12–$13 million, U.S. $10.5–$11.5 million, and international $3.5–$4.5 million.
Q2 adjusted gross margin expected at 37–39%, and adjusted EBITDA between negative $2 million and break even.
Full-year 2025 revenue guidance maintained at $165–$175 million, with adjusted EBITDA range increased to $20–$24 million.
Management remains cautiously optimistic for 2025, but notes risks from tariffs, commodity prices, and global trade tensions.
Free cash flow after distributions projected at $7–$11 million for 2025.
Latest events from NCS Multistage
- 2025 delivered double-digit revenue and EBITDA growth, with 2026 guidance projecting further gains.NCSM
Q4 20256 Mar 2026 - Q2 2024 revenue up 17% with improved margins and raised 2024 guidance on strong international growth.NCSM
Q2 20242 Feb 2026 - Q3 2024 revenue up 15% year-over-year, with strong global demand and margin expansion.NCSM
Q3 202417 Jan 2026 - Strong 2024 growth, innovation, and international expansion drive robust margins and free cash flow.NCSM
Emerging Growth Virtual Conference27 Dec 2025 - Record international growth, margin expansion, and strong cash position highlight 2024 results.NCSM
Q4 202425 Dec 2025 - Up to $200M in common stock registered for sale, supporting growth amid oilfield sector risks.NCSM
Registration Filing16 Dec 2025 - Strong international growth, margin expansion, and strategic acquisitions drive robust free cash flow.NCSM
Sidoti's Year End Virtual Investor Conference12 Dec 2025 - Stockholders will vote on directors, auditor, executive pay, and an expanded equity plan.NCSM
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and executive pay approval.NCSM
Proxy Filing1 Dec 2025